Literature DB >> 31617742

Evaluation of homocysteine in the diagnosis and prognosis of coronary slow flow syndrome.

Nan Li1,2, Liuyang Tian1,3, Jiefeng Ren1, Yang Li1, Yuqi Liu1,4,5,6.   

Abstract

Aim: To identify the exact molecular markers related to coronary slow flow syndrome (CSFS) and its prognosis. Patients & methods: Data from 54 patients with CSFS diagnosed by coronary angiography and 101 normal control patients were collected and analyzed.
Results: Logistic regression analysis confirmed that homocysteine (Hcy; odds ratio: 1.107; 95% CI: 1.018-1.205; p = 0.018) was associated with CSFS. Receiver-operating characteristic curve analysis identified an Hcy value of 17.1 μmol/l as an effective cut-off point for predicting CSFS. Cox survival analysis showed a relationship between high admission Hcy level (odds ratio: 1.19; 95% CI = 1.05-1.34; p = 0.005) and recurrent angina.
Conclusion: Our results showed positive correlations of Hcy with CSFS and cardiac events.

Entities:  

Keywords:  coronary slow flow syndrome; correlation; homocysteine; predictor; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31617742     DOI: 10.2217/bmm-2018-0446

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  2 in total

1.  Relationship Between Plasma Total Homocysteine Levels and Mean Corrected TIMI Frame Count in Patients with Acute Myocardial Infarction.

Authors:  Feng Hu; Feng Lu; Xiao Huang; Xiaoshu Cheng
Journal:  Int J Gen Med       Date:  2021-11-15

2.  Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.

Authors:  Hongxin Guo; Xingyuan Li; Mingjun Zhu
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.